In addition to its biological effects in promoting the proliferation and invasion of bladder cancer, the high expression of Derlin-1 can also induce bladder cancer cells to become resistant to cisplatin via the PI3K/AKT and MMP/ERK pathways. This evidence concerns the gene DERL1 and urinary bladder carcinoma.